" Efesovir " (FS-1) for COVID-19, Phase 2
Condition: Covid19 Intervention: Drug: Efesovir Sponsor: Scientific Center for Anti-infectious Drugs, Kazakhstan Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials